Iterative Health and One GI have announced a strategic partnership to advance clinical research as a core ancillary service for OneGI’s community providers, while expanding access to innovative trials.
The collaboration reinforces research as an integral offering in community-based gastroenterology (GI) care across a leading network of independent physician practices.
“Advancing medicine through research is central to our mission of improving health outcomes for our patients and communities,” said Christa Newton, CEO of One GI. “Our partnership with Iterative Health strengthens our established research ancillary through shared expertise and proven support, ensuring our physicians can expand patients’ access to leading-edge treatments.”
One GI’s network includes 34 clinics across six states. Its research ancillary, comprised of 13 active sites, is now an exclusive mainstay in Iterative Health’s global site network.
“We are privileged that One GI has chosen to partner with Iterative Health in our journey to create the highest quality and fastest network of Gastroenterology research sites,” said Jonathan Ng, CEO of Iterative Health. “In partnership with One GI research, we have consistently demonstrated industry-leading results through our unique operating model over the past two years. We look forward to furthering clinical trial innovation together in the years ahead.”
This collaboration brings together One GI’s research capabilities and Iterative Health’s proven site-serving operational model, building on a history of delivering high-quality trials at scale.